Approval · Notice of Compliance 10199 · 2009
NIMOTOP: Notice of Compliance 10199
Issued May 7, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10199
- Date
- May 7, 2009
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: 30 mg/tab
- Therapeutic class
- Calcium channel blocking agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NIMOTOP | 02325926 | Marketed |
Medicinal ingredients
- NIMODIPINE 30 MG per TAB